1. How many patients were diagnosed with prostate cancer over the last 3 months? Of these, how many patients were diagnosed with metastatic prostate cancer?
2. How many prostate cancer patients were treated over the last 3 months with:
a. Docetaxel
b. Abiraterone
c. Enzalutamide
d. Cabazitaxel
3. How many patients have been diagnosed with advanced (FIGO Stages III and IV) ovarian (epithelial ovarian, fallopian tube or primary peritoneal) cancer over the last 3 months? If none, do you refer ovarian cancer patients to another trust, if so which one?
4. Of the ovarian cancer patients diagnosed over the last 3 months, how many have been treated with:
a. Paclitaxel in combination with a platinum-based compound
b. Platinum-based therapy alone (cisplatin or carboplatin)
c. Bevacizumab in combination with paclitaxel and carboplatin
d. Olaparib
e. Niraparib
f. Rucaparib
5. Of the ovarian cancer patients diagnosed over the last 3 months, how many have been tested for the BRCA mutation? And of these, how many tested positive?
6. Of the ovarian cancer patients who were positive for a BRCA mutation, how many patients received?
a. Olaparib for 1st line maintenance
b. Bevacizumab in combination with paclitaxel and carboplatin for 1st line maintenance
